Indo Us Biotech Limited disclosed that Nehaben Sachinbhai Patel has resigned from her post as Non-Executive Independent Director with effect from 21 April 2026. The move, described in the company’s latest governance update, marks a formal end to Patel’s tenure on the board and signals a moment of transition for the company as it steers its independent oversight forward.
Patel’s letter cited personal and unavoidable reasons for stepping down. The notice confirms there are no other material reasons behind the resignation, and that she does not hold directorship in any other listed entity, a detail often watched by investors evaluating board independence.
With Patel’s exit, Indo Us Biotech will assess the impact on its board dynamics and the continuity of independent oversight. In similar transitions, boards typically map out next steps in line with governance best practices, signaling to stakeholders that the company remains focused on maintaining sound oversight while it fills the vacancy.
Patel thanked the company and the board for the opportunity to contribute, while the company extended appreciation for her service as it navigates the next phase of leadership.